- Home
- VRA vs STTK Comparison
VRA vs STTK Comparison
Compare VRA & STTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRA
- STTK
- Stock Information
- Founded
- VRA 1982
- STTK 2016
- Country
- VRA United States
- STTK United States
- Employees
- VRA N/A
- STTK N/A
- Industry
- VRA Apparel
- STTK Biotechnology: Pharmaceutical Preparations
- Sector
- VRA Consumer Discretionary
- STTK Health Care
- Exchange
- VRA Nasdaq
- STTK Nasdaq
- Market Cap
- VRA 162.4M
- STTK 173.6M
- IPO Year
- VRA 2010
- STTK 2020
- Fundamental
- Price
- VRA $5.10
- STTK $3.76
- Analyst Decision
- VRA Strong Buy
- STTK Strong Buy
- Analyst Count
- VRA 1
- STTK 3
- Target Price
- VRA $6.00
- STTK $10.67
- AVG Volume (30 Days)
- VRA 661.2K
- STTK 123.5K
- Earning Date
- VRA 09-11-2024
- STTK 11-07-2024
- Dividend Yield
- VRA N/A
- STTK N/A
- EPS Growth
- VRA N/A
- STTK N/A
- EPS
- VRA 0.02
- STTK N/A
- Revenue
- VRA $439,677,000.00
- STTK $4,123,999.00
- Revenue This Year
- VRA $0.38
- STTK $164.45
- Revenue Next Year
- VRA $6.24
- STTK N/A
- P/E Ratio
- VRA $204.77
- STTK N/A
- Revenue Growth
- VRA N/A
- STTK 380.09
- 52 Week Low
- VRA $4.38
- STTK $1.33
- 52 Week High
- VRA $8.35
- STTK $11.76
- Technical
- Relative Strength Index (RSI)
- VRA 38.40
- STTK 53.48
- Support Level
- VRA $4.82
- STTK $3.63
- Resistance Level
- VRA $5.06
- STTK $3.94
- Average True Range (ATR)
- VRA 0.24
- STTK 0.23
- MACD
- VRA -0.03
- STTK 0.05
- Stochastic Oscillator
- VRA 47.60
- STTK 68.42
About VRA Vera Bradley Inc.
Vera Bradley Inc designs women's handbags, travel items, and accessories. Each category comprises a substantial component of total sales, with the bags category comprising the most. most of the company's sales are made directly to customers through Vera Bradley's retail stores and e-commerce sites. The company also has a substantial wholesale business selling to specialty retail and department stores. Almost all company sales are in the United States. Vera Bradley uses third-party manufacturers in Asia to produce its products, and the company distributes the products through its distribution center in Indiana. The Company has three reportable segments: Vera Bradley Direct, Vera Bradley Indirect, and Pura Vida. The majority of revenue is from the Vera Bradley Direct segment.
About STTK Shattuck Labs Inc.
Shattuck Labs Inc is a clinical-stage biotechnology company pioneering the development of dual-sided fusion proteins as an entirely new class of biologic medicine. Its product candidate, SL-172154, has been rationally designed to simultaneously inhibit the CD47/SIRPa checkpoint interaction to restore an anti-tumor immune response and to activate the CD40 costimulatory receptor to bolster an immune response. Its product candidate, SL-279252, which is being developed in collaboration with Takeda Pharmaceuticals, or Takeda, has been rationally designed to simultaneously inhibit the PD-1/PD-L1 interaction and activate the OX40 receptor.